Rani Therapeutics Holdings, Inc.
RANI· Nasdaq
Released Sep 13, 2021, after the close
10-Q filed Sep 13, 2021, 75 days after period end · 0000950170-21-001789
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Revenue | $1.96M | $60.00K |
| Net Income | -$5.49M | -$2.71M |
| EPS Diluted | -$0.12 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rani Therapeutics Holdings, Inc. · CIK 1856725 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2021 · filed Sep 13, 2021 · 75 d after period end
9.1% from the close of Sep 13, 2021 to the close of Sep 14, 2021, the first after the release.